Form 8-K - Current report:
SEC Accession No. 0001104659-23-126929
Filing Date
2023-12-18
Accepted
2023-12-18 17:00:17
Documents
12
Period of Report
2023-12-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333074d1_8k.htm   iXBRL 8-K 26917
  Complete submission text file 0001104659-23-126929.txt   196168

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aptx-20231215.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aptx-20231215_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aptx-20231215_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2333074d1_8k_htm.xml XML 3154
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

EIN.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38535 | Film No.: 231494542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)